Skip to main content

Table 4 Probability of target T >4 × MIC attainment for various MICs

From: Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock

  

Adequate PK N (%)

MIC (μg/mL)

Target concentration (μg/mL)

meropenem (n = 16)

ceftazidime (n = 18)

cefepime (n = 19)

piperacillin-tazobactam (n = 27)

32

128

0

0

0

1 (4)

16

64

0

0

1 (5)

12 (44)

8

32

0

5 (28)

3 (16)

15 (56)

4

16

3 (18)

14 (78)

7 (36)

21 (78)

2

8

12 (75)

18 (100)

15 (79)

25 (93)

1

4

15 (94)

18 (100)

17 (90)

27 (100)

0.5

2

16 (100)

18 (100)

19 (100)

27 (100)

  1. Data are expressed as counts (percentage). In bold: MIC corresponding to European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoints for Pseudomonas aeruginosa.
  2. MIC, minimal inhibitory concentration; PK, pharmacok inetics.